DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE

N/A

Manufactured by Major Pharmaceuticals

2,218 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE

DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Major Pharmaceuticals. The most commonly reported adverse reactions for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE include PAIN, FATIGUE, NAUSEA, RASH, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE.

Top Adverse Reactions

PAIN70 reports
FATIGUE68 reports
NAUSEA63 reports
RASH59 reports
DIARRHOEA56 reports
HEADACHE54 reports
PRODUCT DOSE OMISSION ISSUE48 reports
PRURITUS46 reports
PNEUMONIA45 reports
COVID 1944 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION44 reports
VOMITING43 reports
CHRONIC KIDNEY DISEASE40 reports
ANXIETY38 reports
FALL37 reports
OFF LABEL USE35 reports
MALAISE34 reports
DYSPNOEA33 reports
WEIGHT DECREASED33 reports
DIZZINESS31 reports
DEATH30 reports
DRUG INEFFECTIVE30 reports
URINARY TRACT INFECTION30 reports
ASTHENIA29 reports
INFLUENZA28 reports
RENAL FAILURE28 reports
ACUTE KIDNEY INJURY27 reports
EMOTIONAL DISTRESS27 reports
URTICARIA26 reports
BACK PAIN25 reports
COUGH25 reports
DECREASED APPETITE24 reports
ABDOMINAL PAIN UPPER23 reports
ANHEDONIA23 reports
PAIN IN EXTREMITY23 reports
PYREXIA23 reports
SINUSITIS23 reports
ARTHRALGIA22 reports
FEELING ABNORMAL21 reports
CONSTIPATION20 reports
PRODUCT USE IN UNAPPROVED INDICATION20 reports
HOSPITALISATION19 reports
ASTHMA18 reports
CHILLS18 reports
HYPERSENSITIVITY18 reports
NASOPHARYNGITIS18 reports
ABDOMINAL PAIN17 reports
BLOOD PRESSURE INCREASED17 reports
GAIT DISTURBANCE17 reports
INFUSION RELATED REACTION17 reports
INFUSION SITE PAIN17 reports
MIGRAINE17 reports
DRUG HYPERSENSITIVITY16 reports
EAR INFECTION16 reports
HYPERTENSION16 reports
INFECTION16 reports
OSTEOPOROSIS16 reports
DEPRESSION15 reports
ILLNESS15 reports
ABDOMINAL DISCOMFORT14 reports
ALOPECIA14 reports
BONE DENSITY DECREASED14 reports
END STAGE RENAL DISEASE14 reports
INCORRECT DOSE ADMINISTERED14 reports
INJECTION SITE PAIN14 reports
PERIPHERAL SWELLING14 reports
SEPSIS14 reports
WEIGHT INCREASED14 reports
BRONCHITIS13 reports
CONTUSION13 reports
ERYTHEMA13 reports
HEART RATE INCREASED13 reports
SOMNOLENCE13 reports
ECONOMIC PROBLEM12 reports
SEIZURE12 reports
UPPER RESPIRATORY TRACT INFECTION12 reports
VIRAL INFECTION12 reports
ABDOMINAL DISTENSION11 reports
CONDITION AGGRAVATED11 reports
DRY SKIN11 reports
INSOMNIA11 reports
INSURANCE ISSUE11 reports
MUSCLE SPASMS11 reports
RESPIRATORY TRACT INFECTION11 reports
DEHYDRATION10 reports
PRODUCT USE ISSUE10 reports
RASH PRURITIC10 reports
STRESS10 reports
SWELLING10 reports
THERAPY INTERRUPTED10 reports
TREMOR10 reports
ANAEMIA9 reports
CHEST PAIN9 reports
GASTROINTESTINAL DISORDER9 reports
GASTROOESOPHAGEAL REFLUX DISEASE9 reports
HERPES ZOSTER9 reports
HYPERHIDROSIS9 reports
INFUSION SITE ERYTHEMA9 reports
INJECTION SITE PRURITUS9 reports
OSTEOPENIA9 reports

Report Outcomes

Out of 759 classified reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE:

Serious 58.5%Non-Serious 41.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female483 (68.9%)
Male218 (31.1%)

Reports by Age

Age 5919 reports
Age 6118 reports
Age 6618 reports
Age 6016 reports
Age 5815 reports
Age 6514 reports
Age 5413 reports
Age 4512 reports
Age 6212 reports
Age 7812 reports
Age 5511 reports
Age 3910 reports
Age 4810 reports
Age 5110 reports
Age 5710 reports
Age 6710 reports
Age 7410 reports
Age 439 reports
Age 448 reports
Age 498 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE?

This profile reflects 2,218 FDA FAERS reports that mention DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE?

Frequently reported terms in FAERS include PAIN, FATIGUE, NAUSEA, RASH, DIARRHOEA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE?

Labeling and FAERS entries often list Major Pharmaceuticals in connection with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.